Ranbaxy gets tentative FDA nod to make, market hypertension treatment …
Forbes - MUMBAI (Thomson Financial) - India’s Ranbaxy Laboratories Ltd said it received tentative approval from the US Food and Drug Administration to manufacture and market amlodipine besylate tablets of 2.5 mg, 5 mg and 10 mg strengths. Amlodipine besylate …
